Curavida Medical Research Group is a dedicated Phase II–IV clinical trial site in Miami, led by board-certified dermatologists and backed by Latitude Dermatology Group's established patient base.
Curavida Medical Research Group is a dedicated dermatology clinical trial site founded by Dr. Arvin S. Jadoo, a board-certified dermatologist and experienced Mohs surgeon trained at the University of Pennsylvania and the University of Miami. We are purpose-built to deliver rigorous, protocol-compliant Phase II–IV clinical research from day one.
Operating in co-space with Latitude Dermatology Group at 6301 Biscayne Blvd, our site combines the agility of a new, sponsor-focused research organization with immediate access to an established, diverse patient population spanning the full spectrum of dermatologic conditions.
Our mission is to bring tomorrow's dermatology treatments to the patients of South Florida — safely, efficiently, and with the highest standard of scientific integrity.
Participating in a clinical study at Curavida is straightforward. Here's what to expect.
We conduct Phase II–IV FDA-regulated dermatology trials, leveraging Latitude Dermatology Group's active patient population for efficient, targeted enrollment across a wide range of conditions.
Our co-space partnership with Latitude Dermatology Group gives sponsors something rare in a new site — immediate access to a large, established patient database from day one.
Curavida operates within Latitude Dermatology Group's Miami practice — an active, high-volume dermatology clinic at 6301 Biscayne Blvd. Active clinical patients with documented diagnoses can be identified and approached for study eligibility right away, dramatically compressing recruitment timelines and reducing screen-fail rates.
Patients remain under ongoing dermatologic care at Latitude throughout study participation, ensuring strong medical oversight, long-term follow-up compliance, and a natural pathway for re-enrollment into future studies.
While Curavida Medical Research Group is a new site, we are not a blank slate. Our principal investigator brings Ivy League medical training, a Chief Residency at the University of Miami, and peer-reviewed publications in dermatology's most prestigious journals. Our co-investigator contributes over 25 years of dermatology and Mohs surgery expertise. Our CRC brings 15 years of hands-on dermatology experience. And our co-space with Latitude Dermatology Group means we arrive at your SQV with real patients, real relationships, and real infrastructure — not promises alone.
Whether you're a patient interested in a study or a sponsor looking to discuss a partnership, we'd love to hear from you.